These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11308401)

  • 1. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine.
    Oram RJ; Daum RS; Seal JB; Lauderdale DS
    JAMA; 2001 Apr; 285(14):1874-9. PubMed ID: 11308401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination practices in hospital newborn nurseries before and after changes in vaccination recommendations.
    Clark SJ; Cabana MD; Malik T; Yusuf H; Freed GL
    Arch Pediatr Adolesc Med; 2001 Aug; 155(8):915-20. PubMed ID: 11483119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of thimerosal-related changes in hepatitis B vaccine birth-dose recommendations on childhood vaccination coverage.
    Luman ET; Fiore AE; Strine TW; Barker LE
    JAMA; 2004 May; 291(19):2351-8. PubMed ID: 15150207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the 1999 AAP/USPHS joint statement on thimerosal in vaccines on infant hepatitis B vaccination practices.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Feb; 50(6):94-7. PubMed ID: 11263794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the thimerosal controversy on hepatitis B vaccine coverage of infants born to women of unknown hepatitis B surface antigen status in Michigan.
    Biroscak BJ; Fiore AE; Fasano N; Fineis P; Collins MP; Stoltman G
    Pediatrics; 2003 Jun; 111(6 Pt 1):e645-9. PubMed ID: 12777580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccine coverage among infants born to women without prenatal screening for hepatitis B virus infection: effects of the Joint Statement on Thimerosal in Vaccines.
    Thomas AR; Fiore AE; Corwith HL; Cieslak PR; Margolis HS
    Pediatr Infect Dis J; 2004 Apr; 23(4):313-8. PubMed ID: 15071284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn hepatitis B vaccination policy in hospital nurseries.
    Cabana MD; Aiken KD; Clark SJ
    Pediatrics; 2002 Feb; 109(2):E21. PubMed ID: 11826231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
    Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
    Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thimerosal recommendations on hospitals' neonatal hepatitis B vaccination policies.
    Brayden RM; Pearson KA; Jones JS; Renfrew BL; Berman S
    J Pediatr; 2001 May; 138(5):752-5. PubMed ID: 11343056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B vaccination among children in inner-city public housing, 1991-1997.
    Lauderdale DS; Oram RJ; Goldstein KP; Daum RS
    JAMA; 1999 Nov; 282(18):1725-30. PubMed ID: 10568644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
    JAMA; 2001 Mar; 285(12):1568-70. PubMed ID: 11302135
    [No Abstract]   [Full Text] [Related]  

  • 13. Reasons hospitals give for not offering hepatitis B vaccine to low-risk newborns.
    Aiken KD; Clark SJ; Cabana MD
    Clin Pediatr (Phila); 2002; 41(9):681-6. PubMed ID: 12462318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of revised nursery orders on newborn preventive services.
    Madlon-Kay DJ
    J Am Board Fam Med; 2011; 24(6):656-64. PubMed ID: 22086808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal characteristics and hospital policies as risk factors for nonreceipt of hepatitis B vaccine in the newborn nursery.
    O'Leary ST; Nelson C; Duran J
    Pediatr Infect Dis J; 2012 Jan; 31(1):1-4. PubMed ID: 21941215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.
    Lin ND; Kleinman K; Chan KA; Yu XJ; France EK; Wei F; Mullooly JP; Black S; Shay DK; Kolczak M; Lieu TA;
    BMC Pediatr; 2006 Nov; 6():31. PubMed ID: 17101052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccine use in Cincinnati: a community's response to the AAP recommendation of universal hepatitis B immunization.
    Siegel RM; Baker RC; Kotagal UR; Balistreri WF
    J Natl Med Assoc; 1994 Jun; 86(6):444-8. PubMed ID: 8078082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in newborn hepatitis B vaccination by birth year cohorts-1998-2007, USA.
    Zhao Z; Murphy TV; Jacques-Carroll L
    Vaccine; 2011 Dec; 30(1):14-20. PubMed ID: 22063390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes, practices, and preferences of pediatricians regarding initiation of hepatitis B immunization at birth.
    Cooper A; Yusuf H; Rodewald L; Malik T; Pollard R; Pickering L
    Pediatrics; 2001 Dec; 108(6):E98. PubMed ID: 11731625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.